8750
document
Endometrial cytodiagnosis using a new softcyte versus a conventional endocyte . A new endometrial cytologic sampling device , softcyte , was used in cytological screening for endometrial cancer , and was compared with the endocyte with regard to manipulability , adverse effects ( including pain and hemorrhage ) , and cellular findings ( including the quantity of cells collected , the success rate , cell freshness , and cellular clumping ) . A total of 315 women ( premenopause 251 , postmenopause 64 ) were randomly assigned to two groups who underwent the endometrial cytological screening with either the softcyte or the endocyte . To assess the value of the softcyte we compared it with the endocyte . Endometrial cytology using a softcyte or an endocyte achieved high correct diagnosis rate for cancer , and both instruments are valuable as endometrial cytologic sample devices . The softcyte causes only mild pain on introduction and during collection , and a large quantity of cells could be harvested . These results suggest that the softcyte is a useful cytologic sampling device in screening for endometrial cancer .
8751
Intervention_Other
softcyte
8752
Intervention_Other
endocyte
8753
Intervention_Other
endocyte
8754
Intervention_Other
endometrial cytological screening
8755
Intervention_Other
softcyte
8756
Intervention_Other
endocyte
8757
Intervention_Other
softcyte
8758
Intervention_Other
endocyte
8759
Intervention_Other
softcyte
8760
Intervention_Other
endocyte
8761
Outcome_Other
correct diagnosis rate for
8762
Outcome_Physical
cancer
8763
Outcome_Pain
mild pain on introduction and during collection
8764
Outcome_Physical
quantity of cells
8765
Participant_Sample-size
315 women
8766
Participant_Sample-size
251
8767
Participant_Sample-size
64